Development of monoclonal antibody-mediated interventions to combat malaria

NIH RePORTER · NIH · N43 · $298,596 · view on reporter.nih.gov ↗

Abstract

This contract is to provide proof of concept studies for the development of a monoclonal antibody to combat P. falciparum malaria.

Key facts

NIH application ID: 10712195
Project number: 75N93022C00022-0-9999-1
Recipient: SANARIA, INC.
Principal Investigator: SUSAN RUPPRECHT
Activity code: N43
Funding institute: NIH
Fiscal year: 2022
Award amount: $298,596
Award type: —
Project period: 2022-08-30 → 2023-08-31